# Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis

> **NCT04144101** · PHASE4 · COMPLETED · sponsor: **Chung Shan Medical University** · enrollment: 40 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Etoricoxib
- **DRUG:** Aceclofenac

## Key facts

- **NCT ID:** NCT04144101
- **Lead sponsor:** Chung Shan Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03-01
- **Primary completion:** 2007-07-31
- **Final completion:** 2007-07-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04144101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04144101, "Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04144101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*